https://www.businesswire.com/news/home/20241106393263/en/Sarepta-Therapeutics-Announces-Third-Quarter-2024-Financial-Results-and-Recent-Corporate-Developments
Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter ...
sarepta therapeuticsthird quarterfinancial resultsannouncesrecent
https://www.financialcontent.com/article/bizwire-2026-5-6-sarepta-therapeutics-announces-first-quarter-2026-financial-results-and-recent-corporate-developments
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the first quarter...
sarepta therapeuticsfirst quarterfinancial resultsannouncesrecent
https://www.sarepta.com/science/manufacturing
Gene Therapy & RNA Manufacturing | Sarepta Therapeutics
Learn more about our approach to gene therapy and RNA manufacturing.
gene therapysarepta therapeuticsrnamanufacturing
https://www.taiwanpoliticalreporter.com/article/835928934-sarepta-therapeutics-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-for-more-information-srpt
Sarepta Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi &...
sarepta therapeuticssecurities lawincsuedviolations
https://warriortradingnews.com/2015/10/02/sarepta-therapeutics-srpt-stock-spikes-up-on-positive-study/
Sarepta Therapeutics (SRPT) Stock | Spikes Up On Positive Study - Warrior Trading News
sarepta therapeuticsspikes upsrptstockpositive
https://www.sarepta.com/es/node/141
Patient Affairs | Sarepta Therapeutics
Sarepta is committed to providing support at every stage of a patient’s journey. Our partnerships with patient advocacy groups are fundamental to this work....
sarepta therapeuticspatientaffairs
https://www.parentprojectmd.org/sarepta-therapeutics-announces-update-on-elevidys-label-company-restructuring/
Sarepta Therapeutics Announces Update on ELEVIDYS Label, Company Restructuring - Parent Project...
Jul 17, 2025 - Yesterday afternoon, Sarepta issued a press release and community letter which included updates related to the non-ambulatory label for ELEVIDYS. While...
sarepta therapeuticsannouncesupdateelevidyslabel
https://www.insidertrades.com/sarepta-therapeutics-inc-stock/
SRPT Insider Trading | Sarepta Therapeutics Buys and Sells
Which executives are buying and selling shares of Sarepta Therapeutics stock? View the most recent SRPT insider trading activity at InsiderTrades.com.
insider tradingsarepta therapeuticssrptbuyssells
https://www.seattlechildrens.org/research/research-studies-clinical-trials/current-studies/all/a-long-term-observational-study-evaluating-sarepta-therapeutics-incs-exon-skipping-therapies-in-patients-with-duchenne-muscular-dystrophy-under-conditions-of-routine-clinical-practice-study00002656/
A Long-term Observational Study Evaluating Sarepta Therapeutics, Inc's Exon-Skipping Therapies in...
An observational study that is designed to collect available data on DMD patients receiving an FDA approved exon skipping drug in routine clinical...
a longobservational studysarepta therapeuticsexon skippingterm
https://www.needhamco.com/transactions/sarepta-therapeutics-3/
Sarepta Therapeutics - Needham
sarepta therapeuticsneedham
https://public.com/stocks/srpt/options-chain?expiration=2026-12-18
Buy Sarepta Therapeutics (SRPT) Call and Put Options - Options Chain
sarepta therapeuticsput optionsbuysrptcall
https://kehoelawfirm.com/sarepta-therapeutics-srpt/
Sarepta Therapeutics - SRPT - Kehoe Law Firm
Jun 26, 2025 - Kehoe Law Firm, P.C. is investigating potential violations of federal securities laws and claims on behalf of investors of Sarepta Therapeutics, Inc.
sarepta therapeuticslaw firmsrptkehoe